| scholarly article | Q13442814 |
| P50 | author | Wenge Liu | Q54918179 |
| P2093 | author name string | Mark W Dewhirst | |
| Fan Yuan | |||
| Ashutosh Chilkoti | |||
| Matthew R Dreher | |||
| Charles R Michelich | |||
| P2860 | cites work | Openings between defective endothelial cells explain tumor vessel leakiness | Q24681507 |
| The vesiculo-vacuolar organelle (VVO). A new endothelial cell permeability organelle | Q28205729 | ||
| Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin | Q28239719 | ||
| Recent advances with liposomes as pharmaceutical carriers | Q29616702 | ||
| Drug delivery systems: entering the mainstream | Q29618136 | ||
| HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action | Q33935270 | ||
| Fluorescence photobleaching with spatial Fourier analysis: measurement of diffusion in light-scattering media | Q34020177 | ||
| Ligand-targeted therapeutics in anticancer therapy | Q34152775 | ||
| Block copolymer micelles for drug delivery: design, characterization and biological significance | Q34184381 | ||
| Delivery of molecular and cellular medicine to solid tumors | Q34190339 | ||
| Microvascular permeability of normal and neoplastic tissues | Q34385472 | ||
| Selective activation of anticancer prodrugs by monoclonal antibody–enzyme conjugates | Q34463640 | ||
| Effect of pegylation on pharmaceuticals | Q35075776 | ||
| The dawning era of polymer therapeutics | Q35128900 | ||
| Role of tumor-host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors. | Q35283331 | ||
| Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. | Q35461362 | ||
| Advancing the field of drug delivery: taking aim at cancer | Q35604818 | ||
| Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment | Q36477445 | ||
| Macromolecular carrier systems for targeted drug delivery: pharmacokinetic considerations on biodistribution | Q40937831 | ||
| HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity | Q44345826 | ||
| Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470. | Q44775111 | ||
| Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats. | Q47189752 | ||
| Available space and extracellular transport of macromolecules: effects of pore size and connectedness | Q47192612 | ||
| Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier | Q47364175 | ||
| Experimental studies on the uptake and retention of labelled proteins in a rat tumour | Q47915591 | ||
| Patterns of proliferation related to vasculature in human head-and-neck carcinomas before and after transplantation in nude mice | Q53986808 | ||
| The ultrastructure and permeability characteristics of the blood vessels of a transplantable rat sarcoma. | Q54794767 | ||
| Early Phase Tumor Accumulation of Macromolecules: A Great Difference in Clearance Rate between Tumor and Normal Tissues | Q54951534 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | macromolecule | Q178593 |
| P304 | page(s) | 335-344 | |
| P577 | publication date | 2006-03-01 | |
| P1433 | published in | Journal of the National Cancer Institute | Q400279 |
| P1476 | title | Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers | |
| P478 | volume | 98 |
| Q41518143 | A Biomimetic Microfluidic Tumor Microenvironment Platform Mimicking the EPR Effect for Rapid Screening of Drug Delivery Systems |
| Q33677713 | A Facile Method to Probe the Vascular Permeability of Nanoparticles in Nanomedicine Applications |
| Q39638742 | A Novel GAP460 Biopolymer for Use as a Carrier in Drug-Delivery Applications |
| Q42965017 | A ceramic-based anticancer drug delivery system to treat breast cancer. |
| Q30441056 | A compartment model of VEGF distribution in blood, healthy and diseased tissues. |
| Q87816690 | A dextran-based probe for the targeted magnetic resonance imaging of tumours expressing prostate-specific membrane antigen |
| Q92678136 | A lanthanide-peptide-derived bacterium-like nanotheranostic with high tumor-targeting, -imaging and -killing properties |
| Q27308658 | A liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or density |
| Q43066289 | A mechanistic compartmental model for total antibody uptake in tumors |
| Q51376358 | A mixture theory model of fluid and solute transport in the microvasculature of normal and malignant tissues. I. Theory |
| Q50501230 | A mixture theory model of fluid and solute transport in the microvasculature of normal and malignant tissues. II: Factor sensitivity analysis, calibration, and validation |
| Q33835328 | A modeling analysis of the effects of molecular size and binding affinity on tumor targeting |
| Q41110202 | A novel approach to tracer-kinetic modeling for (macromolecular) dynamic contrast-enhanced MRI. |
| Q36119564 | A novel lipid-based nanomicelle of docetaxel: evaluation of antitumor activity and biodistribution |
| Q34765364 | A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment |
| Q37619943 | A physiological perspective on the use of imaging to assess the in vivo delivery of therapeutics. |
| Q27006569 | A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics |
| Q37327582 | A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer |
| Q47348224 | Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size |
| Q38127266 | Actively targeting solid tumours with thermoresponsive drug delivery systems that respond to mild hyperthermia |
| Q36892526 | Alk5 inhibition increases delivery of macromolecular and protein-bound contrast agents to tumors |
| Q83061673 | Amphiphilic micelles of poly(2-methyl-2-carboxytrimethylene carbonate-co- -lactide)-graft-poly(ethylene glycol) for anti-cancer drug delivery to solid tumours |
| Q33839139 | An imaging-driven model for liposomal stability and circulation |
| Q37998494 | Analysis of Immediate Stress Mechanisms upon Injection of Polymeric Micelles and Related Colloidal Drug Carriers: Implications on Drug Targeting |
| Q38794462 | Analyzing spatiotemporal distribution of uniquely fluorescent nanoparticles in xenograft tumors. |
| Q37187003 | Antibody tumor penetration: transport opposed by systemic and antigen-mediated clearance. |
| Q55030497 | Anticancer nanoparticulate polymer-drug conjugate. |
| Q52578442 | Application of a Novel Murine Ear Vein Model to Evaluate the Effects of a Vascular Radioprotectant on Radiation-Induced Vascular Permeability and Leukocyte Adhesion. |
| Q30455958 | Application of optical imaging and spectroscopy to radiation biology |
| Q36000025 | Aquaporin-1 facilitates pressure-driven water flow across the aortic endothelium |
| Q91721673 | Assessing micrometastases as a target for nanoparticles using 3D microscopy and machine learning |
| Q64120121 | Assessment of Intratumoral Doxorubicin Penetration after Mild Hyperthermia-Mediated Release from Thermosensitive Liposomes |
| Q33317965 | Biofunctional polymer nanoparticles for intra-articular targeting and retention in cartilage |
| Q49601103 | Bioorthogonal Masking of Circulating Antibody-TCO Groups Using Tetrazine-Functionalized Dextran Polymers |
| Q47297973 | Biotransport kinetics and intratumoral biodistribution of malonodiserinolamide-derivatized [60]fullerene in a murine model of breast adenocarcinoma |
| Q34502853 | Blood vessel hyperpermeability and pathophysiology in human tumour xenograft models of breast cancer: a comparison of ectopic and orthotopic tumours |
| Q92151508 | CEST MRI monitoring of tumor response to vascular disrupting therapy using high molecular weight dextrans |
| Q36936207 | COMPARATIVE PHARMACOKINETICS OF PAMAM-OH DENDRIMERS AND HPMA COPOLYMERS IN OVARIAN-TUMOR-BEARING MICE |
| Q39005226 | Cancer nanomedicine: progress, challenges and opportunities |
| Q34447986 | Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. |
| Q33887986 | Cancer targeted therapeutics: From molecules to drug delivery vehicles. |
| Q36417295 | Challenges and opportunities in the advancement of nanomedicines |
| Q26748018 | Challenges and strategies in anti-cancer nanomedicine development: An industry perspective |
| Q37209899 | Challenges in the development of magnetic particles for therapeutic applications |
| Q33627998 | Characterization of tumor microvascular structure and permeability: comparison between magnetic resonance imaging and intravital confocal imaging |
| Q47296077 | Characterization of tumor vascular permeability using natural dextrans and CEST MRI. |
| Q55040576 | Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice. |
| Q39601840 | Cisplatin-loaded gelatin-poly(acrylic acid) nanoparticles: Synthesis, antitumor efficiency in vivo and penetration in tumors |
| Q37616184 | Clearance Kinetics and Clearance Routes of Molecules From the Suprachoroidal Space After Microneedle Injection |
| Q37765187 | Clinical developments in nanotechnology for cancer therapy |
| Q34478394 | Co-encapsulation of Doxorubicin with galactoxyloglucan nanoparticles for intracellular tumor-targeted delivery in murine ascites and solid tumors. |
| Q41952431 | Colloidal Gold-Mediated Delivery of Bleomycin for Improved Outcome in Chemotherapy. |
| Q35842769 | Combined-modality radioimmunotherapy: synergistic effect of paclitaxel and additive effect of bevacizumab |
| Q28484470 | Comparison of conventional chemotherapy, stealth liposomes and temperature-sensitive liposomes in a mathematical model |
| Q37013422 | Comparison of nanoparticle penetration into solid tumors and sites of inflammation: studies using targeted and nontargeted liposomes |
| Q37888875 | Computational approaches to the rational design of nanoemulsions, polymeric micelles, and dendrimers for drug delivery |
| Q57050134 | Contributions of the glycocalyx, endothelium, and extravascular compartment to the blood-brain barrier |
| Q36932025 | Controlled cellular uptake and drug efficacy of nanotherapeutics |
| Q30837863 | Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA. |
| Q36166672 | Crizotinib (PF‐02341066) reverses multidrug resistance in cancer cells by inhibiting the function of P‐glycoprotein |
| Q38691508 | Crossing the barrier: treatment of brain tumors using nanochain particles |
| Q27002209 | Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines |
| Q42812737 | De novo design of supercharged, unfolded protein polymers, and their assembly into supramolecular aggregates |
| Q28283802 | Design of a novel class of protein-based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkers |
| Q38067265 | Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery. |
| Q38270094 | Designing a better theranostic nanocarrier for cancer applications |
| Q38152205 | Designing protein-based biomaterials for medical applications |
| Q28484446 | Detoxifying antitumoral drugs via nanoconjugation: the case of gold nanoparticles and cisplatin |
| Q30715520 | Diamagnetic chemical exchange saturation transfer (diaCEST) liposomes: physicochemical properties and imaging applications |
| Q39515605 | Differential distribution of blood-derived proteins in xenografted human adenocarcinoma tissues by in vivo cryotechnique and cryobiopsy |
| Q27333617 | Differential mechanisms associated with vascular disrupting action of electrochemotherapy: intravital microscopy on the level of single normal and tumor blood vessels |
| Q30404975 | Distribution of doxorubicin in rats undergoing ultrasonic drug delivery |
| Q34835853 | Docetaxel-encapsulating small-sized polymeric micelles with higher permeability and its efficacy on the orthotopic transplantation model of pancreatic ductal adenocarcinoma |
| Q39563556 | Doxorubicin release from self-assembled nanoparticles of deoxycholic acid-conjugated dextran. |
| Q30424484 | Drug delivery to the brain by focused ultrasound induced blood-brain barrier disruption: quantitative evaluation of enhanced permeability of cerebral vasculature using two-photon microscopy |
| Q29614404 | Drug penetration in solid tumours |
| Q38612537 | Drug-Loaded Perfluorocarbon Nanodroplets for Ultrasound-Mediated Drug Delivery |
| Q36497444 | Dynamic, long-term in vivo imaging of tumor-stroma interactions in mouse models of breast cancer using spinning-disk confocal microscopy |
| Q30490487 | Dynamics of different-sized solid-state nanocrystals as tracers for a drug-delivery system in the interstitium of a human tumor xenograft |
| Q92980207 | Effect of Formulation and Processing Parameters on the Size of mPEG- b-p(HPMA-Bz) Polymeric Micelles |
| Q28544295 | Effect of antigen shedding on targeted delivery of immunotoxins in solid tumors from a mathematical model |
| Q34018204 | Effect of pazopanib on tumor microenvironment and liposome delivery |
| Q38403588 | Effect of size and pegylation of liposomes and peptide-based synthetic lipoproteins on tumor targeting |
| Q30575798 | Effect of small-molecule modification on single-cell pharmacokinetics of PARP inhibitors |
| Q92734093 | Effects of Focused-Ultrasound-and-Microbubble-Induced Blood-Brain Barrier Disruption on Drug Transport under Liposome-Mediated Delivery in Brain Tumour: A Pilot Numerical Simulation Study |
| Q26783746 | Emerging Applications for Optically Enabled Intravital Microscopic Imaging in Radiobiology |
| Q57376444 | Emerging functional nanomaterials for therapeutics |
| Q88175900 | Engineered Charge Redistribution of Gp2 Proteins through Guided Diversity for Improved PET Imaging of Epidermal Growth Factor Receptor |
| Q35981121 | Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release |
| Q38876382 | Enhancing Accumulation and Penetration of HPMA Copolymer-Doxorubicin Conjugates in 2D and 3D Prostate Cancer Cells via iRGD Conjugation with an MMP-2 Cleavable Spacer |
| Q30356887 | Enhancing Tumor Penetration of Nanomedicines. |
| Q37560183 | Environmentally responsive peptides as anticancer drug carriers |
| Q92989402 | Evaluating Nanoparticles in Preclinical Research Using Microfluidic Systems |
| Q52653127 | Evaluating tumor metastatic potential by imaging intratumoral acidosis via pH-activatable near-infrared fluorescent probe. |
| Q35551143 | Evaluation of drug loading, pharmacokinetic behavior, and toxicity of a cisplatin-containing hydrogel nanoparticle |
| Q53381586 | Evaluation of interstitial protein delivery in multicellular layers model |
| Q37233080 | Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity |
| Q28082374 | Exploring the tumor microenvironment with nanoparticles |
| Q42199782 | Extended Time-lapse Intravital Imaging of Real-time Multicellular Dynamics in the Tumor Microenvironment. |
| Q89547961 | Extension of a multiphase tumour growth model to study nanoparticle delivery to solid tumours |
| Q92785837 | Extradomain-B Fibronectin-Targeted Dextran-Based Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Probe for Detecting Pancreatic Cancer |
| Q92482163 | FGF2 engineered SPIONs attenuate tumor stroma and potentiate the effect of chemotherapy in 3D heterospheroidal model of pancreatic tumor |
| Q42018361 | Fabrication of elastin-like polypeptide nanoparticles for drug delivery by electrospraying |
| Q41807570 | Factors determining antibody distribution in tumors |
| Q35860275 | Fentanyl Enhances Hepatotoxicity of Paclitaxel via Inhibition of CYP3A4 and ABCB1 Transport Activity in Mice |
| Q51418752 | Flow dynamics control endothelial permeability in a microfluidic vessel bifurcation model |
| Q47324299 | Fluorescence imaging of the lymph node uptake of proteins in mice after subcutaneous injection: molecular weight dependence. |
| Q38067857 | Fluorescent Macromolecular Sensors of Enzymatic Activity for In Vivo Imaging |
| Q30448172 | Fluorochrome-functionalized nanoparticles for imaging DNA in biological systems |
| Q37960848 | Folate-Linked Drugs for the Treatment of Cancer and Inflammatory Diseases |
| Q39060269 | From Composition to Cure: A Systems Engineering Approach to Anticancer Drug Carriers. |
| Q58108514 | Functional Nanomaterials for Biomedical Research: Focus on Bio-Functionalization, Biosynthesis, and Biomedical Applications |
| Q34353772 | Fusion of cell-penetrating peptides to thermally responsive biopolymer improves tumor accumulation of p21 peptide in a mouse model of pancreatic cancer |
| Q36291569 | GRPR-targeted Protein Contrast Agents for Molecular Imaging of Receptor Expression in Cancers by MRI |
| Q41571715 | Gefitinib-loaded DSPE-PEG2000 nanomicelles with CD133 aptamers target lung cancer stem cells |
| Q37735165 | Gold nanoparticles: opportunities and challenges in nanomedicine |
| Q33711448 | Hand-held spectroscopic device for in vivo and intraoperative tumor detection: contrast enhancement, detection sensitivity, and tissue penetration |
| Q89664742 | HemoSYS: A Toolkit for Image-based Systems Biology of Tumor Hemodynamics |
| Q39584434 | Hepatic arterial infusion (HAI) with PEGylated liposomes containing 5-FU improves tumor control of liver metastases in a rat model |
| Q36211450 | High contrast tumor imaging with radio-labeled antibody Fab fragments tailored for optimized pharmacokinetics via PASylation |
| Q33828697 | High efficiency of alphaviral gene transfer in combination with 5-fluorouracil in a mouse mammary tumor model. |
| Q31038938 | Highly stable noble metal nanoparticles dispersible in biocompatible solvents: synthesis of cationic phosphonium gold nanoparticles in water and DMSO. |
| Q37578241 | Hindlimb heating increases vascular access of large molecules to murine tibial growth plates measured by in vivo multiphoton imaging |
| Q88578958 | Histidine-rich glycoprotein-induced vascular normalization improves EPR-mediated drug targeting to and into tumors |
| Q38100772 | Human ferritin for tumor detection and therapy. |
| Q36550798 | Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer |
| Q34883565 | Hyperthermia-enhanced indocyanine green delivery for laser-induced thermal ablation of carcinomas |
| Q38586888 | Image-driven pharmacokinetics: nanomedicine concentration across space and time |
| Q33576048 | Image-guided local delivery strategies enhance therapeutic nanoparticle uptake in solid tumors |
| Q36994932 | Image-guided tumor surgery: will there be a role for fluorescent nanoparticles? |
| Q34340761 | Imaging of Cells and Nanoparticles: Implications for Drug Delivery to the Brain |
| Q49502555 | Imaging of Nanoparticle Distribution to Assess Treatments That Alter Delivery. |
| Q35082792 | Improved functionality of the vasculature during conventionally fractionated radiation therapy of prostate cancer |
| Q35101117 | Improved modeling of in vivo kinetics of slowly diffusing radiotracers for tumor imaging |
| Q35641963 | Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-beta signaling. |
| Q50467668 | Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin |
| Q45069548 | In Vivo Application of Proton-Electron Double-Resonance Imaging |
| Q61902697 | In Vivo Performance of a Liposomal Vascular Contrast Agent for CT and MR-Based Image Guidance Applications |
| Q34151598 | In situ growth of a PEG-like polymer from the C terminus of an intein fusion protein improves pharmacokinetics and tumor accumulation |
| Q38405765 | In vitro microfluidic models of tumor microenvironment to screen transport of drugs and nanoparticles |
| Q53306641 | In vivo distribution of polymeric nanoparticles at the whole-body, tumor, and cellular levels |
| Q37383842 | In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer |
| Q33738557 | In vivo imaging of nanoparticle delivery and tumor microvasculature with multimodal optical coherence tomography |
| Q36297880 | In vivo molecular imaging and histological analysis of changes induced by electric pulses used for plasmid DNA electrotransfer to the skin: a study in a dorsal window chamber in mice. |
| Q30423888 | In vivo optical molecular imaging and analysis in mice using dorsal window chamber models applied to hypoxia, vasculature and fluorescent reporters. |
| Q64094904 | In vivo rendezvous of small nucleic acid drugs with charge-matched block catiomers to target cancers |
| Q33738607 | In vivo spectral and fluorescence microscopy comparison of microvascular function after treatment with OXi4503, Sunitinib and their combination in Caki-2 tumors |
| Q37171112 | Increased nanoparticle penetration in collagenase-treated multicellular spheroids |
| Q33823794 | Injectable intratumoral depot of thermally responsive polypeptide-radionuclide conjugates delays tumor progression in a mouse model |
| Q36366424 | Intracellular-signaling tumor-regression modeling of the pro-apoptotic receptor agonists dulanermin and conatumumab |
| Q28553638 | Intravital Microscopy Imaging Approaches for Image-Guided Drug Delivery Systems |
| Q36909845 | Intravital imaging and cell invasion |
| Q46619385 | Intravital microscopic analysis of vascular perfusion and macromolecule extravasation after photodynamic vascular targeting therapy |
| Q34507643 | Intravital microscopy as a tool to study drug delivery in preclinical studies |
| Q33405268 | Intravital microscopy of tumor angiogenesis and regression in the dorsal skin fold chamber: mechanistic insights and preclinical testing of therapeutic strategies |
| Q34442139 | Investigating the optimal size of anticancer nanomedicine. |
| Q28485922 | Investigation of the spatiotemporal responses of nanoparticles in tumor tissues with a small-scale mathematical model |
| Q53020846 | Liposome encapsulated albumin-paclitaxel nanoparticle for enhanced antitumor efficacy |
| Q42745039 | Longitudinal investigation of permeability and distribution of macromolecules in mouse malignant transformation using PET. |
| Q38728427 | Low levels of physiological interstitial flow eliminate morphogen gradients and guide angiogenesis |
| Q30557217 | Macromolecule extravasation-xenograft size matters: a systematic study using probe-based confocal laser endomicroscopy (pCLE) |
| Q38616007 | Magnetic Resonance-Guided Drug Delivery |
| Q34140082 | Maternally sequestered therapeutic polypeptides - a new approach for the management of preeclampsia |
| Q92938316 | Mathematical modeling of the heterogeneous distributions of nanomedicines in solid tumors |
| Q92423949 | Matrix Metalloproteinase-sensitive Multistage Nanogels Promote Drug Transport in 3D Tumor Model |
| Q33666994 | Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles |
| Q36782265 | Mechanisms of tumor vascular priming by a nanoparticulate doxorubicin formulation. |
| Q47797659 | Microfluidic modeling of the biophysical microenvironment in tumor cell invasion |
| Q58121730 | Microglia Induce PDGFRB Expression in Glioma Cells to Enhance Their Migratory Capacity |
| Q39176599 | Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy |
| Q39103231 | Mimicking Tumors: Toward More Predictive In Vitro Models for Peptide- and Protein-Conjugated Drugs |
| Q42284455 | Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma |
| Q64937609 | Mixture theory modeling for characterizing solute transport in breast tumor tissues. |
| Q35203487 | Modeling of microvascular permeability changes after electroporation |
| Q48546618 | Modulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery |
| Q30398463 | Modulation of the interstitial fluid pressure by high intensity focused ultrasound as a way to alter local fluid and solute movement: insights from a mathematical model |
| Q55039164 | Molecular Size Modulates Pharmacokinetics, Biodistribution, and Renal Deposition of the Drug Delivery Biopolymer Elastin-like Polypeptide. |
| Q47680427 | Molecular engineering solutions for therapeutic peptide delivery. |
| Q37283095 | Monitoring of release of cargo from nanocarriers by MRI/MR spectroscopy (MRS): significance of T2/T2* effect of iron particles. |
| Q53653115 | Monte Carlo calculation of the maximum therapeutic gain of tumor antivascular alpha therapy |
| Q34241923 | Multichannel imaging to quantify four classes of pharmacokinetic distribution in tumors |
| Q38870955 | Multimodal approach to assess tumour vasculature and potential treatment effect with DCE-US and DCE-MRI quantification in CWR22 prostate tumour xenografts |
| Q36807158 | Multimodal in vivo imaging exposes the voyage of nanoparticles in tumor microcirculation. |
| Q56995871 | Multiscale homogenization for fluid and drug transport in vascularized malignant tissues |
| Q37259677 | Multiscale imaging and computational modeling of blood flow in the tumor vasculature. |
| Q28078448 | NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer? |
| Q91872045 | Nano-Enhanced Drug Delivery and Therapeutic Ultrasound for Cancer Treatment and Beyond |
| Q43952374 | Nanoparticle accumulation in angiogenic tissues: towards predictable pharmacokinetics. |
| Q29615628 | Nanoparticle therapeutics: an emerging treatment modality for cancer |
| Q38978632 | Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures |
| Q36803827 | Nanoscale Drug Delivery Systems for Enhanced Drug Penetration into Solid Tumors: Current Progress and Opportunities |
| Q36953404 | Nanoscale Drug Delivery and Hyperthermia: The Materials Design and Preclinical and Clinical Testing of Low Temperature-Sensitive Liposomes Used in Combination with Mild Hyperthermia in the Treatment of Local Cancer |
| Q83686151 | Nanospheres-Incorporated Implantable Hydrogel as a Trans-Tissue Drug Delivery System |
| Q39571083 | Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel |
| Q51144814 | Naphthalene-fused BODIPY near-infrared dye as a stable contrast agent for in vivo photoacoustic imaging |
| Q57493973 | Near-infrared fluorescence lymphatic imaging in vascular endothelial growth factor-C overexpressing murine melanoma |
| Q36057369 | Neratinib reverses ATP-binding cassette B1-mediated chemotherapeutic drug resistance in vitro, in vivo, and ex vivo. |
| Q37879444 | New short interfering RNA-based therapies for glomerulonephritis |
| Q37020622 | Non-invasive dynamic near-infrared imaging and quantification of vascular leakage in vivo. |
| Q33877554 | Non-specific binding and steric hindrance thresholds for penetration of particulate drug carriers within tumor tissue |
| Q34048859 | Noninvasive visualization of in vivo release and intratumoral distribution of surrogate MR contrast agent using the dual MR contrast technique. |
| Q30368171 | Novel delivery approaches for cancer therapeutics. |
| Q51848856 | Numerical simulation of blood and interstitial flow through a solid tumor |
| Q37419973 | On-command drug release from nanochains inhibits growth of breast tumors. |
| Q42362784 | Optimizing molecular weight of octyl chitosan as drug carrier for improving tumor therapeutic efficacy |
| Q37973892 | Optimizing radioimmunoconjugate delivery in the treatment of solid tumor |
| Q36454792 | Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors |
| Q34011141 | PEG-farnesyl thiosalicylic acid telodendrimer micelles as an improved formulation for targeted delivery of paclitaxel |
| Q35159784 | PEG-like nanoprobes: multimodal, pharmacokinetically and optically tunable nanomaterials |
| Q39430827 | Paclitaxel in tyrosine-derived nanospheres as a potential anti-cancer agent: In vivo evaluation of toxicity and efficacy in comparison with paclitaxel in Cremophor |
| Q40072763 | Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelle nanocarriers: pharmacokinetic disposition, tolerability, and cytotoxicity. |
| Q36154645 | Patterns of Vasculature in Mouse Models of Lung Cancer Are Dependent on Location |
| Q40578734 | Penetration of endothelial cell coated multicellular tumor spheroids by iron oxide nanoparticles |
| Q98178368 | Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies |
| Q37362252 | Peptide-based Biopolymers in Biomedicine and Biotechnology |
| Q33514627 | Percutaneous window chamber method for chronic intravital microscopy of sensor-tissue interactions |
| Q37214820 | Perspectives in vector development for systemic cancer gene therapy. |
| Q37245063 | Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements |
| Q30466278 | Phase-shift, stimuli-responsive drug carriers for targeted delivery |
| Q30450131 | Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer |
| Q42444375 | Phenomenological model of interstitial fluid pressure in a solid tumor. |
| Q88510807 | Photoacoustic imaging of tumour vascular permeability with indocyanine green in a mouse model |
| Q34039413 | Physicochemical Properties of Epidermal Growth Factor Receptor Inhibitors and Development of a Nanoliposomal Formulation of Gefitinib |
| Q36838803 | Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles |
| Q38248809 | Plasma and cellular pharmacokinetic considerations for the development and optimization of antitumor block copolymer micelles |
| Q84199396 | Polymer micelles with hydrazone-ester dual linkers for tunable release of dexamethasone |
| Q90012215 | Polymer size affects biodistribution and placental accumulation of the drug delivery biopolymer elastin-like polypeptide in a rodent pregnancy model |
| Q38644304 | Practical theoretic guidance for the design of tumor-targeting agents. |
| Q37816960 | Preclinical development of molecular-targeted agents for cancer |
| Q62492324 | Predicting drug-target interactions using Lasso with random forest based on evolutionary information and chemical structure |
| Q33773319 | Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle. |
| Q36982570 | Prodrug strategies in anticancer chemotherapy |
| Q47394923 | Production of limit size nanoliposomal systems with potential utility as ultra-small drug delivery agents |
| Q57467401 | Progression-dependent transport heterogeneity of breast cancer liver metastases as a factor in therapeutic resistance |
| Q52942218 | Push-pull type meso-ester substituted BODIPY near-infrared dyes as contrast agents for photoacoustic imaging |
| Q30430195 | Quantification of transient increase of the blood-brain barrier permeability to macromolecules by optimized focused ultrasound combined with microbubbles |
| Q45046519 | Quantitative Fluorescence Microscopy Measures Vascular Pore Size in Primary and Metastatic Brain Tumors |
| Q30580276 | Quantity and accessibility for specific targeting of receptors in tumours |
| Q30436623 | Rational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice. |
| Q39329750 | Real-Time Assessment of Ultrasound-Mediated Drug Delivery Using Fibered Confocal Fluorescence Microscopy |
| Q36029752 | Real-Time Imaging Reveals Local, Transient Vascular Permeability, and Tumor Cell Intravasation Stimulated by TIE2hi Macrophage-Derived VEGFA. |
| Q91239698 | Real-time in vivo two-photon imaging study reveals decreased cerebro-vascular volume and increased blood-brain barrier permeability in chronically stressed mice |
| Q27306235 | Real-time visualization and quantitation of vascular permeability in vivo: implications for drug delivery |
| Q38648236 | Realistic biological approaches for improving thermoradiotherapy. |
| Q28085438 | Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery |
| Q46312070 | Recombinant peptide constructs for targeted cell penetrating peptide-mediated delivery |
| Q33534381 | Recursive directional ligation by plasmid reconstruction allows rapid and seamless cloning of oligomeric genes |
| Q58557198 | Restriction of drug transport by the tumor environment |
| Q38585885 | Review: in vitro microvessel models. |
| Q33969360 | Role of boronic acid moieties in poly(amido amine)s for gene delivery |
| Q39667014 | S-Nitrosated Human Serum Albumin Dimer is not only a Novel Anti-Tumor Drug but also a Potentiator for Anti-Tumor Drugs with Augmented EPR Effects |
| Q34275000 | Self-assembled nanoscale coordination polymers with trigger release properties for effective anticancer therapy |
| Q36026705 | Sensitivity analysis of an image-based solid tumor computational model with heterogeneous vasculature and porosity |
| Q34297263 | Significance and applications of nanoparticles in siRNA delivery for cancer therapy |
| Q37385796 | Simultaneous imaging of tumor oxygenation and microvascular permeability using Overhauser enhanced MRI. |
| Q38780383 | Small Molecules for Active Targeting in Cancer |
| Q37059874 | Small-molecule delivery by nanoparticles for anticancer therapy |
| Q33716767 | Spatio-temporal modeling of nanoparticle delivery to multicellular tumor spheroids |
| Q55443292 | Spatiotemporal endothelial cell - pericyte association in tumors as shown by high resolution 4D intravital imaging. |
| Q33553779 | Spatiotemporal temperature distribution and cancer cell death in response to extracellular hyperthermia induced by gold nanorods |
| Q36421133 | Spatiotemporally photoradiation-controlled intratumoral depot for combination of brachytherapy and photodynamic therapy for solid tumor |
| Q30430620 | Stereocomplexed poly(lactic acid)-poly(ethylene glycol) nanoparticles with dual-emissive boron dyes for tumor accumulation |
| Q36821419 | Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy. |
| Q36307519 | Stimuli-responsive nanoparticles for targeting the tumor microenvironment. |
| Q37775972 | Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery. |
| Q33995719 | Strategies for advancing cancer nanomedicine |
| Q41780443 | Subcellular trafficking of FGF controls tracheal invasion of Drosophila flight muscle |
| Q37016869 | Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance |
| Q59806144 | Synergistic enzymatic and bioorthogonal reactions for selective prodrug activation in living systems |
| Q36562731 | Synthesis and biological response of size-specific, monodisperse drug-silica nanoconjugates. |
| Q36563662 | Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages |
| Q39017790 | Synthesis of a carborane-containing cholesterol derivative and evaluation as a potential dual agent for MRI/BNCT applications. |
| Q35565769 | Synthetic tumor networks for screening drug delivery systems |
| Q36680180 | Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance |
| Q41696512 | The Effect of Cage Shape on Nanoparticle-Based Drug Carriers: Anticancer Drug Release and Efficacy via Receptor Blockade Using Dextran-Coated Iron Oxide Nanocages. |
| Q30529631 | The Interactions between L-tyrosine based nanoparticles decorated with folic acid and cervical cancer cells under physiological flow |
| Q43683984 | The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate |
| Q39840480 | The antiproliferative cytostatic effects of a self-activating viridin prodrug |
| Q37865441 | The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery |
| Q50438161 | The dependence of efficiency of transmembrane molecular transfer using electroporation on medium viscosity |
| Q48033850 | The effects of non-invasive radiofrequency electric field hyperthermia on biotransport and biodistribution of fluorescent [60]fullerene derivative in a murine orthotopic model of breast adenocarcinoma |
| Q38071901 | The holistic 3M modality of drug delivery nanosystems for cancer therapy |
| Q53232977 | The influence of tumour blood perfusion variability on thermal damage during nanoparticle-assisted thermal therapy |
| Q37738211 | Theranostic Nucleic Acid Binding Nanoprobe Exerts Anti-inflammatory and Cytoprotective Effects in Ischemic Injury. |
| Q37564522 | Therapeutic peptides for cancer therapy. Part I - peptide inhibitors of signal transduction cascades. |
| Q96136118 | Three-dimensional bioprinted glioblastoma microenvironments model cellular dependencies and immune interactions |
| Q30524355 | Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function. |
| Q39121501 | Tissue-engineered 3D microvessel and capillary network models for the study of vascular phenomena. |
| Q37668337 | Top-down particle fabrication: control of size and shape for diagnostic imaging and drug delivery |
| Q92626169 | Toward the Optimization of Click-Mediated Pretargeted Radioimmunotherapy |
| Q47793665 | Transient and Local Expression of Chemokine and Immune Checkpoint Traps To Treat Pancreatic Cancer. |
| Q27330421 | Transient mild hyperthermia induces E-selectin mediated localization of mesoporous silicon vectors in solid tumors |
| Q38132105 | Transport barriers and strategies of antitumor nanocarriers delivery system |
| Q50082408 | Transport of drugs from blood vessels to tumour tissue. |
| Q52656539 | Trapping effect on a small molecular drug with vascular-disrupting agent CA4P in rodent H22 hepatic tumor model: in vivo magnetic resonance imaging and postmortem inductively coupled plasma atomic emission spectroscopy |
| Q38155500 | Triggered Nanoparticles as Therapeutics. |
| Q36326953 | Triple stimulus-responsive polypeptide nanoparticles that enhance intratumoral spatial distribution |
| Q39390493 | Tumor Accumulation, Penetration, and Antitumor Response of Cisplatin-Loaded Gelatin/Poly(acrylic acid) Nanoparticles |
| Q53274852 | Tumor angiogenesis: when the Tree of Life turns bad |
| Q99579061 | Tumor microenvironment responsive drug delivery systems |
| Q37506109 | Tumor vasculature-targeted recombinant mutated human TNF-α enhanced the antitumor activity of doxorubicin by increasing tumor vessel permeability in mouse xenograft models |
| Q36447756 | Tumor-Priming Smoothened Inhibitor Enhances Deposition and Efficacy of Cytotoxic Nanoparticles in a Pancreatic Cancer Model |
| Q42262385 | Tumor-targeted nanomedicines for cancer theranostics |
| Q33263225 | Two-step fluorescence screening of CD21-binding peptides with one-bead one-compound library and investigation of binding properties of N-(2-hydroxypropyl)methacrylamide copolymer-peptide conjugates |
| Q35964472 | Ultrahigh-throughput Generation and Characterization of Cellular Aggregates in Laser-ablated Microwells of Poly(dimethylsiloxane). |
| Q30514138 | Ultrasound Increases Nanoparticle Delivery by Reducing Intratumoral Pressure and Increasing Transport in Epithelial and Epithelial–Mesenchymal Transition Tumors |
| Q30488681 | Ultrasound mediated delivery of drugs and genes to solid tumors |
| Q41860837 | Understanding and overcoming major barriers in cancer nanomedicine |
| Q42134796 | Unexpected multivalent display of proteins by temperature triggered self-assembly of elastin-like polypeptide block copolymers. |
| Q51309917 | Using magnetoferritin nanoprobes for both nuclear and magnetic-resonance imaging |
| Q41952122 | Vascular regeneration by local growth factor release is self-limited by microvascular clearance |
| Q38957484 | Vascular targeting of nanoparticles for molecular imaging of diseased endothelium |
| Q30483920 | Visualizing stromal cell dynamics in different tumor microenvironments by spinning disk confocal microscopy |
| Q33970699 | Wide-field functional imaging of blood flow and hemoglobin oxygen saturation in the rodent dorsal window chamber |
| Q38836415 | iRGD-conjugated DSPE-PEG2000 nanomicelles for targeted delivery of salinomycin for treatment of both liver cancer cells and cancer stem cells |
Search more.